What amount sold does Protogenix Inc. report in Form D filings?

The latest linked filings report $250K sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Protogenix Inc.'s most recent SEC filing?

Protogenix Inc.'s most recent Form D filing was on 2026-02-13.

How many investors does Protogenix Inc. have?

The most recent Form D filing lists 1 investor(s).

Protogenix Inc.

CIK: 0002110349·Biotechnology·ITHACA, NY

Reported Sold

$250,000

Total Filings

Identified Offerings

Last Filed

Feb 13, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

Offering filing timeline

Feb 13, 2026Form D — New notice

Reported sold: $250,000 · Target: $4,200,000

Rule 506(b)·1 investor

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

No Revenues

Reported commissions across identified offerings

N/A

Amendment Rate

Latest reported sold across 1 identified offering

$250,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Christopher PJ Wightman

Executive Officer, Director

Appears on 1 filing

Eric R Pettee

Executive Officer, Director

Appears on 1 filing

Robert Poltrino

Director

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Feb 13, 2026	New	$4,200,000	$250,000	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Swep Bio, Inc.

Biotechnology

Offering target: $4,999,976

Filed Oct 29, 2026